Article Details

AstraZeneca, Alvogen fined in South Korea over alleged stalling of generic cancer drug

Retrieved on: 2022-10-14 09:36:53

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, Alvogen fined in South Korea over alleged stalling of generic cancer drug. View article details on hiswai:

Excerpt

South Korea's Fair Trade Commission ((FTC)) fined AstraZeneca (AZN) and Alvogen 2.6B Korean won (~$1.82M) for alleged stalling of generics to ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up